Two Different 1-Week Quadruple Therapies Given Back-to-Back Consecutive Therapy for Difficult-to-Treat Helicobacter pylori Infection: A Pilot Study.
Jing LiuChao-Ran JiYue-Yue LiChen QiaoJun-Nan HuMeng WanMin-Juan LinBo-Shen LinJuan WangJing ZhaLi-Xiang LiXiu-Li ZuoPublished in: Clinical and translational gastroenterology (2021)
Consecutive therapy, including amoxicillin, tetracycline, and furazolidone, achieved a good eradication rate (>90%), with desirable compliance and tolerability in difficult-to-treat H. pylori infection.